Home
Live Updates
MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344 : vimarsana.com
MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital,...
Related Keywords
Taheer Datoo ,
David Urso ,
Company Board Of Directors ,
Linkedin ,
Nasdaq ,
Pharma Inc ,
Cable Car Capital ,
Anson Funds ,
Clinical Study ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.